Chemours Company (The) Common Stock (CC)

The Chemours Company (NYSECC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, announced the appointment of Damián Gumpel as President of Chemours’ Titanium Technologies (TT) business segment, effective March 3, 2025. Diane Iuliano Picho, who has served as Interim TT Business President since March 2024 has been appointed Chief Enterprise Enablement Officer, effective March 3, 2025. Both will report to Chemours President and CEO, Denise Dignam and serve on the Chemours Executive Team.

The Chemours Company (Chemours) (NYSECC), a global leader in delivering innovative performance chemistry, today announced the appointment of Joseph (Joe) Kava to its Board of Directors, effective January 3, 2025.

The Chemours Company (Chemours) (NYSECC) today announced the successful repricing of its Tranche B-3 Euro denominated Term Loan under its senior secured term loan facility due in August 2028.

The Chemours Company (Chemours) (NYSECC), announced that the PCC Group (PCC) plans to build and operate a chlor-alkali facility on the grounds of Chemours’ titanium dioxide (TiO2) plant in DeLisle, Mississippi (USA) and that PCC and Chemours have entered into a chlorine supply agreement which is subject to certain customary conditions precedent. The new facility will utilize state-of-the-art technology to maximize energy efficiency and provide up to an annual nameplate capacity of 340,000 metric tons once the plant is operational. The co-product, caustic soda, will be sold by PCC to strategic partners and on the open market. Construction is expected to begin in early 2026 with the plant being operational in 2028.

The Chemours Company (Chemours) (NYSECC) today announced the successful repricing of its Tranche B-3 U.S. Dollar-denominated Term Loan under its senior secured term loan facility due in August 2028.

The Chemours Company (Chemours) (NYSECC) today announced it completed its previously announced private offering of $600,000,000 in aggregate principal amount of 8.000% senior unsecured notes due 2033 (the “Notes”) that was exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Notes are Chemours’ senior unsecured obligations and are guaranteed by certain of its subsidiaries.

The Chemours Company (Chemours) (NYSECC) today announced the pricing of its previously announced private offering of $600,000,000 aggregate principal amount of new 8.000% senior notes due 2033 (the “Notes”). The Notes will bear interest at 8.000% per annum and mature on January 15, 2033. Interest on the Notes will be payable semi-annually on January 15 and July 15 of each year, beginning on July 15, 2025. The Notes will be senior unsecured obligations of Chemours and will be guaranteed by certain of its subsidiaries. The offering is expected to close on November 27, 2024, subject to customary closing conditions.

The Chemours Company (Chemours) (NYSECC) today announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes due 2033 (the “Notes”), subject to market and other conditions. The Notes will be senior unsecured obligations of Chemours and will be guaranteed by certain of its subsidiaries. Chemours intends to use the net proceeds from the offering to redeem all of its outstanding euro-denominated 4.000% senior notes due 2026 and the remainder of the net proceeds for general corporate purposes.

The Chemours Company (“Chemours” or “the Company”) (NYSECC), a global leader in delivering innovative performance chemistry through Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the third quarter 2024 and provided an update on the Company’s corporate strategy.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Chemours Company (NYSECC).

The Chemours Company (“Chemours”) (NYSECC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the fourth quarter of 2024. The dividend will be paid on December 16, 2024 to stockholders of record as of the close of business on November 15, 2024.

The Chemours Company (“Chemours” or “the Company”) (NYSECC) today announced that the Company expects to issue its third quarter 2024 financial results before market on Monday, November 4, 2024.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Chemours Company (NYSECC).

The Chemours Company (Chemours) (NYSECC), a global leader in delivering innovative performance chemistry, today announced the development of a low global warming potential (GWP) refrigerant retrofit approach for the automotive aftermarket to support the global phasedown of higher GWP hydrofluorocarbon (HFC) refrigerants. The technical approach developed will provide vehicle owners—and their service technicians—with a simple retrofit procedure to safely and cost effectively replace the legacy R-134a refrigerant in their existing vehicle with the widely-used, low GWP Opteon™ YF (R-1234yf) refrigerant. Opteon™ YF was developed to replace R-134a in new mobile HVAC systems.

A new class-action lawsuit alleges millions of homes and businesses contain carpets infused with so-called “forever chemicals,” a fact that major manufacturers have attempted to cover up for decades, despite alleged awareness of their harms to human health, according to attorneys at Hagens Berman.

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or “the Company”) (NYSECC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CC.

The Chemours Company (Chemours) (NYSECC), a global leader in delivering innovative performance chemistry, today announced the opening of the Chemours Battery Innovation Center (CBIC), a first-in-its-class laboratory facility located at the Chemours Discovery Hub in Newark, Delaware. A multi-million-dollar investment, the CBIC supports the testing and scaling of next generation battery technologies, to enable more sustainable, cost-effective, energy-efficient, and high-performing batteries for hybrid and electric vehicles (EVs).

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or “the Company”) (NYSECC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CC.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company (“Chemours” or “the Company”) (NYSECC) for violations of the securities laws.

The Chemours Company (“Chemours” or “the Company”) (NYSECC), a global leader in delivering innovative performance chemistry through Titanium Technologies (“TT”), Thermal & Specialized Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the second quarter 2024.

The Chemours Company (“Chemours”) (NYSECC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the third quarter of 2024. The dividend will be paid on September 13, 2024 to stockholders of record as of the close of business on August 15, 2024.

The Chemours Company (“Chemours” or “the Company”) (NYSECC) today announced that the Company expects to issue its second quarter 2024 financial results after market close on Thursday, August 1, 2024.

The Chemours Company (“Chemours” or “the Company”) (NYSECC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced that the Mexican government has lifted its prior water intake restrictions, enabling the Company to resume normal operations at its titanium dioxide (TiO2) manufacturing facility in Altamira, Mexico. The Company previously announced a temporary pause in production on May 31, 2024.

The Chemours Company (“Chemours”) (NYSECC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Livingston “Tony” Satterthwaite to its Board of Directors, effective June 12.

The Chemours Company (“Chemours”) (NYSECC), a global chemistry company, today announced that the Science Based Target initiative (SBTi) has approved Chemours’ near-term science-based greenhouse gas (GHG) emissions reduction targets. This includes the Company’s existing goal of an absolute 60% reduction in Scope 1 and 2 GHG emissions by 2030 and a new Scope 3 target to reduce emissions by 25% per ton of production by 2030.